Sildenafil Tablet, Film Coated
Product Images NDC 33342-041

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 33342-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil-100mg-cartons.jpg (Sildenafil 100mg Cartons)

Packaging label for Sildenafil Tablets, USP 100 mg film-coated oral tablets by Macleods Pharmaceuticals Limited. The label indicates a unit-dose package containing 60 tablets (10 x 6) and includes storage instructions and manufacturing information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The NDC number 33342-043-98 is shown.*

FDA Label Image

Sildenafil-25mg-cartons.jpg (Sildenafil 25mg Cartons)

Packaging label for Sildenafil Tablets, USP 25 mg film-coated tablets by Macleods Pharmaceuticals Limited. The box contains 60 unit-dose tablets (10 x 6). The label states the product is prescription-only and includes storage instructions and manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd., India. The label has barcodes and sections for lot, expiration, and serial numbers.*

FDA Label Image

Sildenafil-50mg-cartons.jpg (Sildenafil 50mg Cartons)

Packaging label for Sildenafil Tablets, USP 50 mg, film-coated oral tablets. The box is labeled with the product name, strength, and manufacturer details, Macleods Pharmaceuticals Limited. It contains 60 unit-dose tablets (10 x 6). The label includes storage instructions and mentions the package is not child-resistant.*

FDA Label Image

Fig-1 (Sildenafil Fig 1)

A line chart comparing plasma concentration (ng/mL) of Sildenafil over time (hours) for Sildenafil versus a placebo. The x-axis represents time points from 0 to 24 hours post-dose, and the y-axis shows plasma concentration values. The graph includes two lines, one representing Sildenafil and the other placebo.*

FDA Label Image

Fig-2 (Sildenafil Fig 2)

A line graph titled 'Mean Standing Systolic Blood Pressure Change From Baseline' showing two plotted lines comparing treatment groups over time. The x-axis represents time postdose in hours, and the y-axis shows the change in systolic blood pressure (mm Hg). One line represents placebo and the other represents subjects receiving 25 mg Sildenafil.*

FDA Label Image

Fig-3 (Sildenafil Fig 3)

A line chart titled 'Mean Standing Systolic Blood Pressure Change from Baseline' showing two data series comparing Sildenafil 100 mg and placebo over multiple time points, with the vertical axis labeled as change in blood pressure (mm Hg).*

FDA Label Image

Fig-4 (Sildenafil Fig 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' comparing changes over time (hours) for three groups: Desobedril 100 mg, Sildenafil 100 mg, and Placebo. The y-axis shows blood pressure changes in mmHg, and the x-axis represents time, illustrating comparative trends among the treatments.*

FDA Label Image

Fig-5 (Sildenafil Fig 5)

A line graph comparing percent plasma drug concentration over time for two treatments: generic sildenafil tablets and commercial sildenafil tablets. The x-axis shows time post-dose in hours, and the y-axis shows percent plasma drug concentration, indicating the pharmacokinetic profile for both forms.*

FDA Label Image

Sildenafil-fig-6-part-1.jpg (Sildenafil Fig 6 Part 1)

A bar chart titled "Effect of Sildenafil on Maintenance of Erection by Baseline Score" showing the number of patients at endpoint on the y-axis and baseline scores on the x-axis. Different bars represent varying erection maintenance scores from 0 to 5, illustrating distribution changes with Sildenafil treatment.*

FDA Label Image

Sildenafil-fig-6-part-2.jpg (Sildenafil Fig 6 Part 2)

Bar chart titled "Effect of Placebo on Maintenance of Erection by Baseline Score." It shows the percentage of patients at endpoint on the vertical axis and baseline scores from 0 to 5 on the horizontal axis. Different bars represent scores from 0 to 5 in a legend.*

FDA Label Image

Fig-7 (Sildenafil Fig 7)

A bar chart displaying the percentage of patients reporting improvement by treatment group, comparing placebo and Sildenafil Citrate tablets at 25 mg, 50 mg, and 100 mg doses. The chart shows increasing improvement percentages with higher Sildenafil doses.*

FDA Label Image

Sildenafil-structure.jpg (Sildenafil Structure)

Chemical structure of sildenafil, the active ingredient in Sildenafil film-coated tablets. The diagram shows the molecular arrangement including characteristic rings and functional groups corresponding to sildenafil and an associated carboxylic acid moiety.*

FDA Label Image

666 (Sildenafil Tablets 100 mg 100s)

Sildenafil Tablets, USP 100 mg film-coated tablet label from Macleods Pharmaceuticals Limited. The label includes storage instructions, manufacturer information, and states each tablet contains Sildenafil Citrate USP equivalent to 100 mg Sildenafil. The package size is 100 tablets, distributed by Macleods Pharma USA, Inc.*

FDA Label Image

777 (Sildenafil Tablets 100 mg 30s)

Sildenafil Tablets USP 100 mg film-coated tablets packaging label displaying the product name, strength, and dosage form. The label includes storage instructions, manufacturer information (Macleods Pharmaceuticals Ltd., India), and a count of 30 tablets per package. Macleods Pharma USA, Inc. is listed as the distributor.*

FDA Label Image

123 (Sildenafil Tablets 25 mg 30s)

Label for Sildenafil Tablets, USP 25 mg film-coated oral tablets by Macleods Pharmaceuticals Limited. The label displays dosage strength, storage instructions, manufacturer information including Macleods Pharma USA, Inc. and Oxalis Labs in India, and packaging details for a 30-tablet count.*

FDA Label Image

999 (Sildenafil Tablets 50 mg 100s)

Label for Sildenafil Tablets USP 50 mg film-coated tablets. The label states the strength as 50 mg per tablet and includes information on storage temperature, usual dosage instructions, and dispensing conditions. Manufactured by Macleods Pharma USA, Inc. in Princeton, NJ, and Macleods Pharmaceuticals Ltd. at Oxalis Labs, Baddi, Himachal Pradesh, India. Package contains 100 tablets.*

FDA Label Image

888 (Sildenafil Tablets 50 mg 30s)

Sildenafil 50 mg film-coated tablets label showing dosage strength prominently with instructions for dosage and storage. Manufactured by Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label includes barcodes, prescription-only indication, and a 30 tablet count. Storage instructions specify controlled room temperature handling.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.